Your browser doesn't support javascript.
SARS-CoV-2 in Africa.
Vakcinologie ; 15(2):62-67, 2021.
Article in Czech | EMBASE | ID: covidwho-2057597
ABSTRACT
The earliest cases of COVID-19 disease in Africa were, in most cases, the result of imports from abroad. The Democratic republic of the Congo (DRC) identified the first case at the beginning of 2020. Two days after his return from France, the first patient was tested positively in the capital, Kinshasa. The travel restrictions and status of the state of emergency were announced on 24 March 2020. A lockdown followed. In June of the same year, 11 provinces were already affected by COVID-19 disease. The negative socio-economic impact has occurred and is similar to that in any other country. The DRC does not differ from other African countries or on the issue of infectious diseases such as HIV, malaria, cholera, measles or Ebola virus disease. Recurring Ebola epidemics are addressed by vaccination with Ervebo vaccine. Unlike Ebola, part of the population does not believe in the existence of SARS-CoV-2 and does not respect basic anti-epidemic measures. Medical capacities were very limited at the beginning of the SARS-CoV-2 epidemic, both in terms of diagnosis and testing and availability of treatment (60 ventilators to 83 million inhabitants). The situation is complicated as a result of 20 years continuing wars. Another African country, Guinea, is currently facing not only COVID-19, but also the zoonotic disease of Lassa fever, which has been detected in several patients. Copyright © 2021, Medakta s.r.o.. All rights reserved.
Keywords
Search on Google
Collection: Databases of international organizations Database: EMBASE Language: Czech Journal: Vakcinologie Year: 2021 Document Type: Article

Similar

MEDLINE

...
LILACS

LIS

Search on Google
Collection: Databases of international organizations Database: EMBASE Language: Czech Journal: Vakcinologie Year: 2021 Document Type: Article